Starget Pharma
Starget Pharma is an early-stage clinical company focused on developing a new class of Smart Targeted Radioligands (STRs) for precision oncology, specifically targeting hard-to-heal cancers. Their proprietary AI-driven peptide-based discovery engine, built on "Backbone Dynamics," allows for the rapid identification and optimization of radioligands that deliver high-energy radiation directly to tumoral and metastatic cancer cells while sparing healthy tissues. The company aims to accelerate the evolution of targeted radiopharmaceuticals, making these advanced treatments more accessible and faster to develop. Starget's mission is to accelerate the AI-powered discovery, design, and development of novel, targeted peptide radioligands for a broad range of cancers at scale.
Starget Pharma
Starget Pharma is an early-stage clinical company focused on developing a new class of Smart Targeted Radioligands (STRs) for precision oncology, specifically targeting hard-to-heal cancers. Their proprietary AI-driven peptide-based discovery engine, built on "Backbone Dynamics," allows for the rapid identification and optimization of radioligands that deliver high-energy radiation directly to tumoral and metastatic cancer cells while sparing healthy tissues. The company aims to accelerate the evolution of targeted radiopharmaceuticals, making these advanced treatments more accessible and faster to develop. Starget's mission is to accelerate the AI-powered discovery, design, and development of novel, targeted peptide radioligands for a broad range of cancers at scale.